Place of death of children with complex chronic conditions: cross-national study of 11 countries
Language English Country Germany Media print-electronic
Document type Journal Article
PubMed
28070671
DOI
10.1007/s00431-016-2837-0
PII: 10.1007/s00431-016-2837-0
Knihovny.cz E-resources
- Keywords
- Children, Complex chronic conditions, Cross-national, Paediatric palliative care, Place of death, Population-level,
- MeSH
- Residence Characteristics * MeSH
- Chronic Disease mortality MeSH
- Child MeSH
- Infant MeSH
- Humans MeSH
- Logistic Models MeSH
- Adolescent MeSH
- Hospital Mortality MeSH
- Odds Ratio MeSH
- Terminal Care statistics & numerical data MeSH
- Child, Preschool MeSH
- Cause of Death MeSH
- Sex Distribution MeSH
- Death * MeSH
- Cross-Cultural Comparison MeSH
- Terminally Ill statistics & numerical data MeSH
- Death Certificates MeSH
- Check Tag
- Child MeSH
- Infant MeSH
- Humans MeSH
- Adolescent MeSH
- Male MeSH
- Child, Preschool MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Geographicals
- Europe MeSH
- Canada MeSH
- Republic of Korea MeSH
- Mexico MeSH
- New Zealand MeSH
- United States MeSH
UNLABELLED: Cross-national understanding of place of death is crucial for health service systems for their provision of efficient and equal access to paediatric palliative care. The objectives of this population-level study were to examine where children with complex chronic conditions (CCC) die and to investigate associations between places of death and sex, cause of death and country. The study used death certificate data of all deceased 1- to 17-year-old children (n = 40,624) who died in 2008, in 11 European and non-European countries. Multivariable logistic regression was performed to determine associations between place of death and other factors. Between 24.4 and 75.3% of all children 1-17 years in the countries died of CCC. Of these, between 6.7 and 42.4% died at home. In Belgium and the USA, all deaths caused by CCC other than malignancies were less likely to occur at home, whereas in Mexico and South Korea, deaths caused by neuromuscular diseases were more likely to occur at home than malignancies. In Mexico (OR = 0.91, 95% CI: 0.83-1.00) and Sweden (OR = 0.35, 95% CI: 0.15-0.83), girls had a significantly lower chance of dying at home than boys. CONCLUSION: This study shows large cross-national variations in place of death. These variations may relate to health system-related infrastructures and policies, and differences in cultural values related to place of death, although this needs further investigation. The patterns found in this study can inform the development of paediatric palliative care programs internationally. What is known: • There is a scarcity of population-level studies investigating where children with CCC die in different countries. • Cross-national understanding of place of death provides information to health care systems for providing efficient and equal access to paediatric palliative care. What is new : • There are large cross-national variations in the place of death of children with CCC, with few deathsoccuring at home in some countries whereas hospital deaths are generally most common. • In general, deaths caused by neuromuscular diseases and malignancies occur at home more often thanother CCC.
Center for Palliative Care Michelska Prague Czech Republic
Centre of Palliative Care Teaching Hospital Besancon France
Department of Medical Oncology Ghent University Hospital Ghent Belgium
Department of Neurobiology Care Science and Society Karolinska Institutet Huddinge Sweden
Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden
Dongduk Women's University Seoul South Korea
End of Life Care Research Group Vrije Universiteit Brussel and Ghent University Brussels Belgium
Faculty of Nursing University of Alberta Edmonton AB Canada
Gallagher Family Hospice Hamilton New Zealand
Regional Ministry of Equality Health and Social Policies in Andalusia Seville Spain
See more in PubMed
J Perinatol. 2002 Apr-May;22(3):184-95 PubMed
PLoS One. 2012;7(4):e34188 PubMed
J Palliat Med. 2014 Feb;17(2):183-8 PubMed
Pediatrics. 2012 Dec;130(6):e1463-70 PubMed
Child Care Health Dev. 2010 May;36(3):375-84 PubMed
BMC Palliat Care. 2010 Jun 02;9:10 PubMed
Pediatrics. 2014 Sep;134(3):e765-72 PubMed
J Palliat Med. 2014 Jul;17(7):803-10 PubMed
Asian Pac J Cancer Prev. 2013;14(12):7309-14 PubMed
J Pain Palliat Care Pharmacother. 2014 Jun;28(2):130-4 PubMed
BMC Palliat Care. 2013 Feb 15;12:7 PubMed
BMC Public Health. 2007 Oct 08;7:283 PubMed
Int J Palliat Nurs. 2008 Jun;14(6):287-95 PubMed
Pediatr Blood Cancer. 2011 Sep;57(3):361-8 PubMed
Palliat Med. 2006 Apr;20(3):161-9 PubMed
Pediatrics. 2002 Apr;109(4):656-60 PubMed
J Clin Oncol. 2010 May 1;28(13):2267-73 PubMed
J Palliat Med. 2014 May;17(5):589-91 PubMed
Pediatrics. 2000 Jul;106(1 Pt 2):205-9 PubMed
Policy Brief UCLA Cent Health Policy Res. 2012 Aug;(PB2012-3):1-8 PubMed
J Adv Nurs. 2015 Aug;71(8):1940-7 PubMed
Arch Dis Child. 2010 Sep;95(9):686-9 PubMed
Pediatr Clin North Am. 2014 Aug;61(4):797-821 PubMed
J Palliat Med. 2008 Sep;11(7):973-9 PubMed
J Pain Symptom Manage. 2015 Sep;50(3):375-80 PubMed
Pediatrics. 2000 Aug;106(2 Pt 1):351-7 PubMed
J Pain Symptom Manage. 2014 Nov;48(5):839-51 PubMed
J Clin Oncol. 2015 Feb 1;33(4):357-63 PubMed
J Epidemiol Community Health. 2016 Jan;70(1):17-24 PubMed
Support Care Cancer. 2007 Mar;15(3):243-9 PubMed
Palliat Med. 2013 Sep;27(8):705-13 PubMed
Arch Pediatr Adolesc Med. 2011 Nov;165(11):1020-6 PubMed
Pediatrics. 2001 Jun;107(6):E99 PubMed
J Pain Symptom Manage. 2009 Jan;37(1):33-43 PubMed